High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: Impacts of hiatal hernia and corpus gastritis

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 6, 2000, Pages 729-735

  Hamada, H ^a   Haruma, K ^a   Mihara, M ^a   Kamada, T ^a   Yoshihara, M ^a   Sumii, K ^a   Kajiyama, G ^a   Kawanishi, M ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Hiroshima Mitsubishi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; ESOPHAGITIS; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERNIA, HIATAL; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0034082947     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00758.x     Document Type: Article

References (33)

1. 1 Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-5.
2. 2 Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5.
3. 3 Parsonnet J, Friedman GD, Wandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
4. 4 Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma: Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66: 2569-74.
5. 5 Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6.
6. 6 Yoshihara M, Sumii K, Haruma K, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998; 93: 1090-6.
7. 7 Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 1996; 91: 959-62.
8. 8 Komoto K, Haruma K, Kamada T, et al. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998; 93: 1271-6.
9. 9 Mihara M, Haruma K, Kamada T, et al. Low prevalence of Helicobacter pylori infection in patients with reflux esophagitis. Gut 1996; 39(Suppl. 2): A94(Abstract).
10. 10 Newton M, Bryan R, Burnham WR, Kamm MA. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 1997; 40: 9-13.
11. 11 Varanasi RV, Fantry GT, Wilson KT. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Helicobacter 1998; 3: 188-94.
12. 12 Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte MB, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
13. 13 Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92.
14. 14 Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis. Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
15. 15 Di Mario F, Dal Bò N, Salandin S. et al. The appearance of GORD in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: a 4-year prospective study. Gut 1998; 43(Suppl. 2): A95(Abstract).
16. 16 Talley NJ, Janssens J, Lauritsen K, et al. No increase in reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial. Gastroenterology 1998; 114: A305(Abstract).
17. 17 Stene-Larsen G, Weberg R, Froyshov Larsen I, Bjortuft O, Hoel B, Berstad A. Relationship of overweight to hiatus hernia and reflux oesophagitis. Scand J Gastroenterol 1988; 23: 427-32.
18. 18 Sipponen P, Hyvarinen H, Siurala M. H. pylori corpus gastritis - relation to acid output. J Physiol Pharmacol 1996; 47: 151-9.
19. 19 Haruma K, Mihara M, Okamoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus - evaluation of 24-h pH monitoring. Aliment Pharmacol Ther 1999; 13: 155-62.
20. 20 Yasunaga Y, Shinomura Y, Kanayama S, et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994; 35: 1571-1.
21. 21 Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997; 32: 664-8.
22. 22 Tucci A, Blasco G, Paparo GF. Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med 1997; 336: 957-8.
23. 23 El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic acid hyposecretion. Gastroenterology 1997; 113: 15-24.
24. 24 Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50-7.
25. 25 El-Serag HB, Sonnenberg A, Jamal MM, et al. Corpus gastritis is protective against reflux oesophagitis. Gut 1999; 45: 181-5.
26. 26 Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993; 34: 888-92.
27. 27 El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-91.
28. 28 Konturek SJ, Konturek PC, Brzozowski T, Stachura J, Zembala M. Gastric mucosal damage and adaptive protection by ammonia and ammonium ion in rats. Digestion 1996; 57: 433-45.
29. 29 Hamada H, Haruma K, Manabe N, et al. Protective effect of ammonia on reflux esophagitis in rats. Gastroenterology 1999; 116: A181(Abstract).
30. 30 Mittal RK, Lange RC, McCallum RW. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology 1987; 92: 130-5.
31. 31 Patti MG, Goldberg HI, Arcerito M, Bortolasi L, Tong J, Wag LW. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg 1996; 171: 182-6.
32. 32 Kahrilias PJ, Lin S, Chen J, Manka M. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut 1999; 44: 476-82.
33. 33 Cadiot G, Bruhat A, Rigaud D, et al. Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut 1997; 40: 167-74.